Green Cross Medical Science (XKRX:142280) Cash-to-Debt : 0.39 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Green Cross Medical Science Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Green Cross Medical Science's cash to debt ratio for the quarter that ended in Mar. 2024 was 0.39.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Green Cross Medical Science couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Green Cross Medical Science's Cash-to-Debt or its related term are showing as below:

XKRX:142280' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03 Med: 0.33 Max: 1.08
Current: 0.39

During the past 11 years, Green Cross Medical Science's highest Cash to Debt Ratio was 1.08. The lowest was 0.03. And the median was 0.33.

XKRX:142280's Cash-to-Debt is ranked worse than
65.23% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.92 vs XKRX:142280: 0.39

Green Cross Medical Science Cash-to-Debt Historical Data

The historical data trend for Green Cross Medical Science's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Green Cross Medical Science Cash-to-Debt Chart

Green Cross Medical Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

1.08

0.25

0.05

0.46

0.25

Green Cross Medical Science Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															0.54	0.42	0.31	0.25	0.39

Competitive Comparison of Green Cross Medical Science's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Green Cross Medical Science's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Green Cross Medical Science's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Cross Medical Science's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Green Cross Medical Science's Cash-to-Debt falls into.

Green Cross Medical Science Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Green Cross Medical Science's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	5744.025	/	(17314.094	+	5265.439)
	=	0.25

Green Cross Medical Science's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	11850.834	/	(25029.963	+	5424.453)
	=	0.39

Green Cross Medical Science (XKRX:142280) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Green Cross Medical Science Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Green Cross Medical Science's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Green Cross Medical Science (XKRX:142280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Cross Medical Science Corp (XKRX:142280) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

107, Ihyeon-ro 30beon-gil, Giheung-gu, Gyeonggi-do, Yongin-si, KOR, 16924

Website

http://www.greencross.com

Green Cross Medical Science Corp is a total medical device company. It is engaged in the blood glucose business, kidney hemodialysis business, and blood bag business with the application of its know-how in in-vitro diagnostics. The product portfolio offered by the organization includes diagnostic reagents, diagnostic instruments, blood bag, home medical devices, blood dialysis products and HbA1c/BGMS.

Green Cross Medical Science (XKRX:142280) Headlines

No Headlines